CLEVELAND - The German-based manufacturer of the popular blood thinner Pradaxa will pay $650 million to approximately 4000 patients to settle injury lawsuits.
Boehringer Ingelheim says it settled the claims to "avoid the distraction and uncertainty of lengthy litigation."
Most patients complaints related to claims the company failed to adequately warn patients about the risk of internal bleeding.
In February, an exclusive NewsChannel5 investigation revealed Pradaxa is the most complained about drug in the United States.
Our research found more complaints were filed with the FDA about Pradaxa than any other prescription drug in both 2011 and 2012.
Since it was approved by the FDA in 2010, Pradaxa has been blamed for 1,158 U.S. deaths and 12,494 serious injuries, according to Tom Moore, the senior scientist for drug safety and policy at the Institute for Safe Medication Practices. The ISMP is a non-profit organization that monitors FDA reports.
Pradaxa is used to treat atrial fibrillation, a heart condition that significantly increases the risk of stroke.
Cleveland police reviewed 174 discipline cases
Cleveland police reviewed 174 disciplinary cases in 2014 involving misconduct and improper procedures by Cleveland officers.
One cop in Anderson death had crisis training
Only one Cleveland police officer involved in the death of a 37-year-old mentally ill woman while in police custody received specialized…
Child poisoning from detergent prompt legislation
Highly concentrated laundry detergent in brightly colored, palm-size packets are proving so tempting to young children that 17 members of…
Assisted living center corrects deficiencies
The Ohio Department of Health has approved a plan of correction submitted by a Sagamore Hills assisted living center where a 94-year-old…